2024 年业绩基本符合市场预期雍禾医疗公布2024 年业绩：实现收入18.0 亿元，同比增长1.5%；净亏损2.3 亿元，较23 年净亏损5.5 亿元大幅缩窄，主要原因是关店及内部管理优化导致销售与管理费用降低。全年业绩基本符合市场预期。发展趋势核心业务收入24 年保持平稳，平均消费稳中有升。24 年公司植发业务收入13.3 亿元，同比保持稳定；医疗养固业务收入4.5 亿元，同比+14.8%。...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.